MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UK-05-0009464
Dr Mittal Laboratories Private Limited
Dr Mittal Laboratories Private Limited - pharma in Dehradun, Uttarakhand, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹15 Lakh
▲ 134% YoY
Net loss · FY 2025
₹2.26 Lakh
Net margin -15.1%
EBITDA · FY 2025
-₹2.26 Lakh
EBITDA margin -15.1%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹35 Lakh
Issued & subscribed
Satisfied charges
₹1.83 Cr
No open charges
Company age
21 yrs
Est. 2005
Directors on board
2
As per MCA filings
About Dr Mittal Laboratories Private Limited
Data last updated:
Dr Mittal Laboratories Private Limited is a private limited company based in Dehradun, Uttarakhand, India, a subsidiary of Primeur Farmstead Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 December 2005 and has been in existence for over 21 years.
The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN U24234UR2005PTC031167. Its GSTIN is 05AACCD4463D1Z2 (Uttarakhand). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹35 Lakh. It is led by directors Ankit Gupta and Akansha Gupta.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C – 10/2 Sara Industrial Estate Ltd. Vill. Rampur 23rd Km. Selaqui, Dehradun, Uttarakhand, India – 248197.
As per the financials filed for FY 2025, the company reported a revenue of ₹15 Lakh, a growth of 134% compared to the previous year. For the same year it recorded a net loss of ₹2.26 Lakh (net margin -15.1%) and EBITDA of -₹2.26 Lakh (EBITDA margin -15.1%). Revenue has declined at a compounded annual rate (CAGR) of 2% over three years and 19% over five years.
As per MCA filings, the company has satisfied charges of ₹1.83 Cr on record.
Dr Mittal Laboratories Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-05-0009464). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24234UR2005PTC031167
Registration Number 031167
Incorporation Date 29 December 2005
ROC Uttarakhand
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Parent Company Primeur Farmstead Private Limited
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UK-05-0009464
CIN history
Dr Mittal Laboratories has one previous CIN (Corporate Identification Number): U24234UP2005PTC031167. The current CIN is U24234UR2005PTC031167, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24234UR2005PTC031167 | Current |
| U24234UP2005PTC031167 | Previous |
Recognitions & Rankings of Dr Mittal Laboratories
Contact details
Dr Mittal Laboratories Private Limited's registered office is in Dehradun, Uttarakhand. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC – 10/2 Sara Industrial Estate Ltd. Vill. Rampur 23rd Km. Selaqui, Dehradun, Uttarakhand, India – 248197
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Dr Mittal Laboratories Private Limited, buy the company report.
Comprehensive company report
Dr Mittal Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Dr Mittal Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Dr Mittal Laboratories Private Limited, buy the company report.
Financials of Dr Mittal Laboratories Private Limited
FY 2024 filings availableDr Mittal Laboratories Private Limited reported revenue of ₹15 Lakh (up 134% YoY) for FY 2025.
Revenue · FY 2025
₹15 Lakh ▲ 134%
Net loss · FY 2025
₹2.26 Lakh margin -15.1%
EBITDA · FY 2025
-₹2.26 Lakh margin -15.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 134%
3 years · compounded
▼ 2%
5 years · compounded
▼ 19%
EBITDA CAGR growth
1 year
▲ 83%
3 years · compounded
▲ 52%
5 years · compounded
▲ 51%
Revenue rose 134% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 19%. EBITDA rose 83% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹2.26 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.26 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -15.1% | ||||
| Net Profit Margin | -15.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dr Mittal Laboratories Private Limited, buy the company report.
Board of directors of Dr Mittal Laboratories Private Limited
Dr Mittal Laboratories has 2 current directors and 12 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ankit Gupta Also directs: Devnaagri India Private Limited, J D Global Private Limited, 7Xone Trade and Agencies Private Limited and 1 more | Additional Director | 15 Oct 2016 | 10 Years 0 Months | Current |
| Akansha Gupta Also directs: Devnaagri India Private Limited | Additional Director | 20 Oct 2022 | 4 Years 0 Months | Current |
Peer comparison
Dr Mittal Laboratories Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Synthecis Pharmaceuticals Private Limited | ₹15.07 Lakh (FY 2025) | 854.0% | Hyderabad, Telangana, India | |||
| Dr Mittal Laboratories Private Limitedthis company | ₹15 Lakh (FY 2025) | -₹2.26 Lakh | -15.1% | 134.0% | Dehradun, Uttarakhand, India | |
| 30Mg Pharma Limited | ₹15 Lakh (FY 2025) | 40.0% | Ahmedabad, Gujarat, India | |||
| Risoved Pharma Private Limited | ₹14.97 Lakh (FY 2018) | Pune, Maharashtra, India | ||||
| V-Bros Lifesciences Private Limited | ₹14.9 Lakh (FY 2021) | 41.0% | Roorkee, Uttarakhand, India |
To see the full peer comparison of Dr Mittal Laboratories Private Limited, buy the company report.
Auditor
Dr Mittal Laboratories Private Limited is audited by ANNU JAIN & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ANNU JAIN & ASSOCIATES | FY 2023 | 027451N |
Shareholding
The shareholding of Dr Mittal Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Dr Mittal Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹1.83 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Feb 2009 | 10279818 | Punjab National Bank | ₹10 Lakh | Satisfied | |
| 22 Nov 2008 | 10133331 | Punjab National Bank | ₹7.5 Lakh | Satisfied | |
| 03 Oct 2006 | 10025385 | Punjab National Bank | ₹50 Lakh | Satisfied | |
| 03 Oct 2006 | 10025388 | Punjab National Bank | ₹1.15 Cr | Satisfied |
To see the full charge records of Dr Mittal Laboratories Private Limited, buy the company report.
Total charge records: 4 View all charges
Legal cases
No court or tribunal cases involving Dr Mittal Laboratories Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Dr Mittal Laboratories Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Dr Mittal Laboratories has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AACCD4463D1Z2 | Uttarakhand | Active | 01 Jul 2017 |
| 07AACCD4463D1ZY | Delhi | Active | 30 Mar 2025 |
To see the full GST registrations and return filing status of Dr Mittal Laboratories Private Limited, buy the company report.
Recent activity
Dr Mittal Laboratories Private Limited has 14 board changes on record since 2009: 2 appointments and 12 cessations. The latest: Bhuwan Chandra Pathak ceased to be Additional Director on 05 May 2025.
Ceased
Bhuwan Chandra Pathak ceased to be Additional Director.
AGM
Dr Mittal Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Filing
Dr Mittal Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Uttarakhand.
Charges
A charge registered on 03 Oct 2006 via Charge ID 10025385 with Punjab National Bank was fully satisfied on 27 Mar 2023.
Appointed
Akansha Gupta was appointed as Additional Director.
Ceased
Sagar Gupta ceased to be Director.
Ceased
Vidyanand Singh ceased to be Director.
Ceased
Chandraksh Pant ceased to be Additional Director.
Ceased
Sulekha Gupta ceased to be Additional Director.
Ceased
Jyoti Mittal ceased to be Director.
Ceased
Madan Lal Mittal ceased to be Director.
Ceased
Ankur Rajhans Jain ceased to be Additional Director.
14 earlier events are in the company report.
Frequently asked questions
Dr Mittal Laboratories is an active private limited company based in Dehradun, Uttarakhand, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 December 2005 (21+ years old) and is registered under CIN U24234UR2005PTC031167.
Dr Mittal Laboratories has 2 current directors:
- Ankit Gupta - Additional Director
- Akansha Gupta - Additional Director
The latest financial statements of Dr Mittal Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Dr Mittal Laboratories is 05AACCD4463D1Z2, registered in Uttarakhand. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 07AACCD4463D1ZY (Delhi).
The CIN (Corporate Identification Number) of Dr Mittal Laboratories is U24234UR2005PTC031167. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dr Mittal Laboratories was incorporated on 29 December 2005, making it 21+ years old. It is registered with the Registrar of Companies, Uttarakhand.
The peers of Dr Mittal Laboratories by revenue are Synthecis Pharmaceuticals Private Limited, 30Mg Pharma Limited, Risoved Pharma Private Limited, V-Bros Lifesciences Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Bhuwan Chandra Pathak ceased to be Additional Director on 05 May 2025. Akansha Gupta was appointed as Additional Director on 20 Oct 2022. Sagar Gupta ceased to be Director on 20 Oct 2022. Dr Mittal Laboratories has 14 board changes on record in total.
Yes, Dr Mittal Laboratories is registered as a micro enterprise under Udyam registration (number: UDYAM-UK-05-0009464).
The registered office of Dr Mittal Laboratories is at C – 102 Sara Industrial Estate Ltd. Vill. Rampur 23rd Km. Selaqui, Dehradun, Uttarakhand, India – 248197.
Dr Mittal Laboratories operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages